Brief: Cancer Genetics Files For Non-Timely 10-K With U.S. SEC
14/05/2020 23:12
May 14 (Reuters) - Cancer Genetics Inc CGIX.O :
* CANCER GENETICS - FILES FOR NON-TIMELY 10-K WITH U.S. SEC
Source text: (https://bit.ly/35ZDiQd)
Further company coverage: CGIX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Vyant Bio
See all newsBrief: Vyant Bio Provides Update On Winddown Activities
Brief: Vyant Bio Announces Stockholder Approval Of Plan Of Dissolution
Brief: Vyant Bio Files Form 15 For Voluntary Nasdaq Delisting And SEC Deregistration
Brief: Vyant Bio Announces Filing Of Form 25 For Voluntary Nasdaq Delisting And SEC Deregistration
Brief: Vyant Bio Announces Voluntary Nasdaq Delisting, SEC Deregistration